Similarly to MASLD in subjects with HF, the prevalence of obesity and T2DM was significantly higher in the HF group, likely due to common underlying mechanisms like subclinical inflammation with changes in the hepcidin–ferroportin axis, abnormal endocrine function of adipose tissue and insulin resistance [6,39]. This evidence concerns the gene HAMP and Insulin resistance.